Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 15Neoplasm Metastasis 3Hereditary Sensory and Autonomic Neuropathies 3Squamous Cell Carcinoma of Head and Neck 2Hyperglycemia 2Advanced Breast Cancer 2Vascular Malformations 1Triple Negative Breast Neoplasms 1Solid Tumor 1Skin Diseases, Vascular 1Recurrence 1Ovarian Neoplasms 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Lymphatic Abnormalities 1Lymphangioma, Cystic 1Lymphangioma 1Hormone Receptor Positive Breast Carcinoma 1Head and Neck Neoplasms 1Genetic Diseases, Inborn 1Gastrointestinal Neoplasms 1Fallopian Tube Neoplasms 1Exanthema 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Arteriovenous Malformations 1Anatomic Stage III Breast Cancer AJCC v8 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 36Pemetrexed 28Bevacizumab 26Cisplatin 24Paclitaxel 22Gemcitabine 20Radiotherapy 18Docetaxel 18Erlotinib Hydrochloride 15Gefitinib 11pembrolizumab 6Cetuximab 6capmatinib 5Surgical Procedures, Operative 5Radiosurgery 5aflutinib 4Vinorelbine 4Taxes 4Platinum 4Nivolumab 4Metformin 4pegfilgrastim 3durvalumab 3ceritinib 3apatinib 3Sorafenib 3Radiation 3Neoadjuvant Therapy 3Magnetic Resonance Spectroscopy 3tislelizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Adenocarcinoma of Lung × Alpelisib × Clear all
NCT02276027 2020-12-16

A Phase II, Open Label, Multiple Arm Study of AUY922, BYL719, INC280, LDK378 and MEK162 in Chinese Patients With Advanced Non-small Cell Lung Cancer

Novartis

Phase 2 Completed
66 enrolled 18 charts
Thoracic

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡